reports
Form 8.3 - Apex Fundrock Limited : Form 8.3 - Tyman PLC
Apex Fundrock Limited (MISL) Form 8.3 - Apex Fundrock Limited : Form 8.3 - Tyman PLC 01-May-2024 / 12:47 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Chelverton Asset Management (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trust...
Alliance Trust PLC - Net Asset Value
Alliance Trust PLC - Net Asset Value ALLIANCE TRUST PLC At the close of business Tuesday 30 April 2024: The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was - excluding income, 1242.8p - including income, 1248.4p The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was - excluding income, 1247.8p - including income, 1253.4p For further information, please contact: - Juniper Partners LimitedTel. +44 (0)131 378 0500 Notes Net Asset Values are calculated in ...
Zhejiang Jindun Fans Co.Ltd: 1 director
A director at Zhejiang Jindun Fans Co.Ltd sold 568,100 shares at 16.140CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from Or...
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 millionIncreasing 2024 revenue guidance to $83-85 million, previously $79-81 million Conference call with Q&A today at 08:30 AM ET / 14:30 CET IRVINE, CA, and HERSTAL, BELGIUM – May 1, 2024 () – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced its financial results for the first quarter ended March 31, 2024 an...
- Stephane Foucaud
Criterium Energy Ltd (TSX-V: CEQ): On track
• The work-over programme has started with the first two work-overs having added a total of ~40 bbl/d. The third work-over was not completed as damaged equipment was encountered downhole. • The second tranche of work-overs will start in May. Overall, 12-15 work-overs will be undertaken during 2024, at a pace of 2-3 workovers per month, potentially adding a total of 240-300 boe/d. • The drilling of new wells is expected to start in 3Q24 at a cost of US$1.8 mm per new well. 10 infill development a...
FTI Consulting Appoints Economics and Litigation Expert Bryan Perry as...
FTI Consulting Appoints Economics and Litigation Expert Bryan Perry as a Senior Managing Director WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of economics and litigation expert as a Senior Managing Director in the Center for Healthcare Economics and Policy within the firm’s Economic Consulting segment. Mr. Perry has more than a decade of experience working in antitrust and healthcare markets, specializing in economic analysis for complex commercial litigation matters. In his role at FTI Consulting, Mr. Perry will conduct ...
Duncan Fox: 3 directors
Three Directors at Duncan Fox bought 727,875 shares at 1,050.000CLP. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Pareto Bank ASA: 1 director
A director at Pareto Bank ASA sold 50,500 shares at 58.500NOK and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Katapult to Announce First Quarter 2024 Financial Results on May 15, 2...
Katapult to Announce First Quarter 2024 Financial Results on May 15, 2024 PLANO, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- Katapult Holdings, Inc. (NASDAQ: KPLT), an e-commerce-focused financial technology company, today announced it will release its first quarter 2024 financial results before the market opens on Wednesday, May 15, 2024. The company will host a conference call and webcast to discuss these results at 8:00 AM ET that same day. A live audio webcast of the conference call will be available on the Katapult Investor Relations website at . A replay will be available on the invest...
Minerva Neurosciences Reports First Quarter 2024 Financial Results and...
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates BURLINGTON, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported business updates and financial results for the first quarter of 2024 ending March 31, 2024. Roluperidone NDA Update On February 27, 2024, the Company that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to its New Drug Applic...
Amerigo Announces Results of AGM
Amerigo Announces Results of AGM VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; ARREF:OTC) (“Amerigo” or the “Company”) announces the results of voting at its 2024 Annual General Meeting of Shareholders (the “AGM”) held on April 30, 2024. A total of 75,607,500 common shares were voted at the AGM, representing 45.72% of the votes attached to all outstanding common shares of the Company. Shareholders voted in favour of all items of business before the AGM, including the election of all director nominees as follows: NameVotes by Prox...
Norwegian Cruise Line Holdings Reports Strong First Quarter 2024 Finan...
Norwegian Cruise Line Holdings Reports Strong First Quarter 2024 Financial Results Revenue up 20% year-over-year on strong demand Company beat Q1 guidance across key metrics and raises full year guidance based on strong revenue MIAMI, May 01, 2024 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd., (“NCLC”), “Norwegian Cruise Line Holdings”, “Norwegian”, “NCLH” or the “Company”) today reported financial results for the first quarter ended March 31, 2024 and provided guidance for the second quarter and full year 2024. First Quarter 2...
Repligen Reports First Quarter 2024 Financial Results
Repligen Reports First Quarter 2024 Financial Results Reports first quarter revenue of $151 million Increased new modalities revenue by 16% year-over-yearIncreased Filtration (non-COVID) revenue by 12% year-over-yearAchieved a nine-month book-to-bill ratio of 1.03 WALTHAM, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter (Q1) of 2024, covering the three-month period ended March 31, 2024. The company also reiterated its financial guidan...
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday,...
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 First quarter 2024 financial results to be reported on Tuesday, May 7, 2024 Investor Day to replace first quarter 2024 earnings conference call; quarterly calls to resume regular cadence with second quarter 2024 financial results BEDFORD, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for...
Altimmune to Participate at Two Upcoming Conferences
Altimmune to Participate at Two Upcoming Conferences GAITHERSBURG, Md., May 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer at Altimmune, will present on behalf of the Company at the following two upcoming conferences: BTIG Obesity Health Forum (Virtual Conference)Title: Emerging Therapeutics PanelWednesday, May 8, 2024Panel Discussion at 4:00 pm Eastern Time GLP-1-Based Therapeutics Summit (Philadelphia, PA) Title: Focusing on the Use of GLP-1s in Treating MASH & Fatty Liver Disease...
Stack Capital Invests $8 Million USD Into Canva
Stack Capital Invests $8 Million USD Into Canva Leading global on-line visual communication and collaboration platform170+ million monthly active users, across 190 countries, in 100+ languagesFree cash flow positive in 2023; annualized revenues of US$2+ billion TORONTO, May 01, 2024 (GLOBE NEWSWIRE) -- Stack Capital Group Inc. (TSX:STCK and STCK.WT) (“Stack Capital”) an investment holding company that invests in some of the world’s most innovative and disruptive growth & late-stage private companies, is pleased to announce that it has invested $8 million USD into Canva, Inc. (“Canva” or ...
AppTech Payments Strategic Partner PayToMe.co Honored with Six America...
AppTech Payments Strategic Partner PayToMe.co Honored with Six American Business Awards® for AI and Technological Excellence Prestigious Stevie® Awards announced following three-month judging process evaluating over 12.000 nominations CARLSBAD, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (Nasdaq: APCX) (“AppTech” or the “Company”), a pioneering Fintech company powering frictionless commerce, announces that its strategic partner PayToMe.co has been honored with multiple Stevie® Awards, including two Gold, two Silver, and two Bronze, at the prestigious 22nd Annual Amer...
Zevra Therapeutics to Report First Quarter 2024 Results on May 8, 2024
Zevra Therapeutics to Report First Quarter 2024 Results on May 8, 2024 CELEBRATION, Fla., May 01, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that it will host a conference call and audio webcast on Wednesday, May 8, 2024, at 8:00 a.m. ET, to review its corporate and financial results for the first quarter of 2024. The link to the audio webcast will be accessible via the Investor Relations section of the Company’s website, . To join the meeting by conference call, use the...
Opthea Announces Upcoming Presentations at the Retina World Congress 2...
Opthea Announces Upcoming Presentations at the Retina World Congress 2024 MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration, today announced that two scientific presentations on the sozinibercept (OPT-302) Phase 2 clinical trial results and ongoing Phase 3 clinical trial program will be made at the (RWC), being held from May 9-12, 2...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.